Stay updated with breaking news from Rupesh Kotecha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings were presented during the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023, being held this week in San Diego, CA.
/PRNewswire/ -- GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced interim...
/PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
/PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual...
Watch Dr. Rupesh Kotecha, from Miami Cancer Institute, Baptist Health South Florida, discuss the treatment of brain metastases during the CURE Educated Patient® Breast Cancer Summit at MBCC.